เกี่ยวกับตอนนี้
Last year, we thought California had killed single-family zoning. But this Bay Area enclave would rather have mountain lions than new homes.
Read, listen to, or comment on this article here!
Correction: Woodside has dropped this claim to a wildlife habitat to prevent SB9, though I would still predict other communities making other legal attempts to exempt themselves, and legal battles will probably follow.
-Important References-
Harry's previous Insight on SB9 and 10
-Usual Links-
ภาษาอังกฤษ
สหรัฐอเมริกา
สำเนาบทสนทนา 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
ตอนอื่นๆ ใน PODCAST นี้
Harry and Philip wrap up their series on international institutions and the future of peace by discussing the decline of American hegemony and what it means for international order. Can international institutions pick up the slack? What does the future hold?
--
Visit our website and subscribe to ou…
Today, we’re joined by Professor Thomas J. Main to discuss his recently released book, The Rise of Illiberalism.
-Important References-
The book, The Rise of Illiberalism
Professor Main's Twitter
-Usual Links-
Leave a comment on this interview!
Subscribe to our newsletter!
Listen to Spectacles Out …
Today, we're joined by a very special guest who's with us to discuss healthcare policy, democracy reform, the filibuster, campaign finance, and her dream policy for her home state of Wisconsin. Tune in for our conversation.
-Important References-
Campaign Website
Facebook
Twitter
Instagram
-Usual L…
Harry and Philip discuss today's Insight, "The Disease of Medical Lobbying." We talk the nature of policy fights with lobbyists, cost disease socialism, and more!
-Important References-
Listen to the article we're discussing!
-Usual Links-
Leave a comment!
Subscribe to our newsletter!
Listen to Spe…
ข้อสงวนสิทธิ์: พอดแคสต์และอาร์ตเวิร์คที่ฝังอยู่ในหน้านี้มาจาก Spectacles Media ซึ่งเป็นทรัพย์สินของเจ้าของและไม่มีส่วนเกี่ยวข้องหรือรับรองโดย Listen Notes, Inc.
